-
Deep Learning Uncovers Cardiotoxicity Using iPSC-CMs Screeni
2026-06-03
Grafton et al. introduced a deep learning-based phenotypic screening platform using human iPSC-derived cardiomyocytes to rapidly detect drug-induced cardiotoxicity. This approach enhances early-stage drug discovery by enabling scalable, high-content toxicity assessment of bioactive compounds and novel chemical frameworks.
-
KPT-330 (Selinexor) Workflows: Nuclear Export Inhibition in
2026-06-03
KPT-330 (Selinexor) delivers precise inhibition of CRM1-mediated nuclear export, enabling targeted apoptosis induction and cell cycle arrest across advanced cancer models. This article translates recent breakthroughs into actionable protocols, with special emphasis on combination regimens and troubleshooting for maximal research impact.
-
APEX2 Regulates TERT Expression in Human Embryonic Stem Cell
2026-06-02
This study reveals a novel regulatory role for the DNA repair enzyme APEX2 in promoting efficient expression of telomerase reverse transcriptase (TERT) in human embryonic stem cells. These findings connect DNA repair mechanisms with telomerase regulation, offering new perspectives for stem cell biology and potential cancer therapeutics.
-
Deferoxamine Mesylate: Iron Homeostasis, Ferroptosis, and Tu
2026-06-02
Explore how Deferoxamine mesylate, a premier iron-chelating agent, uniquely intersects iron metabolism, ferroptosis, and tumor immune modulation. This comprehensive review goes beyond iron detoxification, revealing advanced applications and novel mechanistic insights for cutting-edge biomedical research.
-
Lypressin Acetate: Expanding Antidiuretic and Antiviral Fron
2026-06-01
Explore the multifaceted potential of Lypressin acetate, a lysine vasopressin analog, in antidiuretic therapy and emerging antiviral research. This article offers new insights into receptor specificity, translational assay design, and practical limitations for researchers.
-
RWJ 67657: Precision p38 MAPK Inhibition in Inflammatory Mod
2026-06-01
RWJ 67657 (JNJ-3026582) is redefining p38 MAP kinase research with its exceptional selectivity and dual-action mechanism, enabling accurate dissection of inflammatory pathways. Applied workflows leveraging this inhibitor yield robust, reproducible data for cytokine modulation and preclinical model optimization.
-
NEXMIF Overexpression Drives ASD-like Behaviors and Neural D
2026-05-31
This study provides the first direct evidence that overexpression of NEXMIF induces autism-like behaviors and pronounced alterations in neuronal morphology in mice. The findings clarify the functional consequences of NEXMIF duplication, emphasizing its impact on synaptic regulation and neurodevelopmental phenotypes.
-
Staurosporine: Strategic Leverage for Translational Cancer R
2026-05-30
This thought-leadership article explores the mechanistic foundation and translational impact of Staurosporine as a broad-spectrum serine/threonine protein kinase inhibitor. It provides actionable guidance for researchers using APExBIO's Staurosporine in apoptosis and angiogenesis studies, contextualizes high-throughput quantification of fractional killing, and maps evolving best practices for robust, reproducible cancer research.
-
Tetrahydromagnolol: Reliable CB2 Agonist for Metastasis Rese
2026-05-29
This scenario-driven article guides cell biologists and translational researchers through validated best practices for leveraging Tetrahydromagnolol (SKU C5552) in viability, proliferation, and cytotoxicity assays. By addressing real lab challenges—from assay reproducibility to data interpretation and vendor selection—it demonstrates how APExBIO’s Tetrahydromagnolol ensures experimental rigor in cannabinoid receptor research and GPCR signaling studies.
-
L-NMMA Acetate: NOS Pathway Modulation in Research Models
2026-05-29
L-NMMA acetate, also known as N(G)-monomethyl-L-arginine acetate, is a well-characterized inhibitor of all three nitric oxide synthase (NOS) isoforms. It enables precise modulation of nitric oxide signaling in diverse experimental systems. This compound is widely used for dissecting the role of nitric oxide in inflammation, regeneration, and cardiovascular disease research.
-
ML385: Optimizing NRF2 Inhibitor Workflows in Cancer and Fer
2026-05-28
ML385, a potent and selective NRF2 inhibitor, is transforming experimental design in cancer biology and ferroptosis studies. This guide unpacks advanced workflows, troubleshooting strategies, and translational insights grounded in recent in vivo research. Discover how ML385 streamlines NRF2 pathway inhibition and enables robust, reproducible data.
-
IR-1061 Near Infrared Fluorescent Dye: Deep In Vivo Imaging
2026-05-28
IR-1061, a near infrared fluorescent dye from APExBIO, delivers exceptional performance for deep tissue and vascular imaging by combining high NIR-II brightness with minimal background. Unlock advanced experimental workflows and troubleshooting insights to harness IR-1061’s full potential in molecular imaging and photothermal therapy.
-
Streptozotocin in Diabetes Models: Mechanistic Precision and
2026-05-27
Explore the multifaceted role of Streptozotocin in experimental diabetes mellitus induction, with a focus on advanced mechanistic understanding and the latest insights into neuropathy models. This article uniquely synthesizes recent TBK1 research with practical guidance for diabetes research workflows.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody: Protocols & QC Guid
2026-05-27
The HRP Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for sensitive, reproducible detection of rabbit primary antibodies in Western blot, ELISA, and immunohistochemistry workflows. This reagent should not be used for diagnostic or medical applications, nor for detection of non-rabbit or non-IgG targets.
-
Advancing Caspase-8 Detection: Strategic Tools for Translati
2026-05-26
Explore the mechanistic role of caspase-8 in cell death pathways, the translational power of sensitive caspase activity measurement, and how the Caspase-8 Fluorometric Assay Kit from APExBIO redefines experimental standards in apoptosis and neurodegenerative disease research. Drawing from new mechanistic insights into cancer therapy and integrating workflow guidance, this article bridges foundational biology with applied assay strategy.
453 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page